Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication‐overuse headache: Subgroup analysis of PROMISE‐2
PaperCitations, authors & open-access status
Efficacy, tolerability, and safety of eptinezumab in patients with a dual diagnosis of chronic migraine and medication‐overuse headache: Subgroup analysis of PROMISE‐2 is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 102 citations, 2020 year and hybrid oa status.
102
Citations
2020
Year
hybrid
OA Status